Societies

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Societies

Just presented at ASCO24: IMROZ results by C. Ola Landgren – ASCO

Photo taken from ASCO/X

Jun 4, 2024, 16:31

Just presented at ASCO24: IMROZ results by C. Ola Landgren – ASCO

ASCO shared a post on X:

“Just presented at American Society of Clinical Oncology 2024 (ASCO24), IMROZ results- lsatuximab, bortezomib, lenalidomide, and dexamethasone (Isa-VRd) significantly improved Progression-Free Survival (PFS) in patients with transplant-ineligible, newly diagnosed Multiple Myeloma versus Velcade, Revlimid and dexamethasone (VRd) with no new safety concerns.”

Additional information
Source: ASCO/X

ASCO ASCO24 C. Ola Landgren cancer dexamethasone IMROZ Isatuximab multiple myeloma OncoDaily Oncology progression-free survival Revlimid Velcade

Sep 27, 2024, 00:50

Dr. Min Li and Dr. Jemma Arakelyan on the Impact of Precision Medicine on Pancreatic Cancer during CityU-AFCR Symposium

Sep 26, 2024, 23:57

Naveen Pemmaraju: Nice to see so many colleagues form around the world at MPNCoandD Congress

Sep 26, 2024, 18:51

Ending Cancer drug shortages in rural areas - American Society of Clinical Oncology

Sep 26, 2024, 18:47

Sign up for INTERACT EUROPE 100 - SIOP Europe

Sep 26, 2024, 18:26

Sally Wolf: The fastest and slowest 9 months I've ever known

Sep 26, 2024, 18:21

Matti Aapro has been selected as a candidate for a second term on the UICC's Board of Directors - SPCC

Sep 26, 2024, 18:13

Carmen Uscatu: Efficiency means quality

Sep 26, 2024, 18:07

Roupen Odabashian: Is whole body MRI an effective cancer screening tool?

Sep 26, 2024, 18:02

Francisco Esteva: Digital breast tomosynthesis, more effective in breast cancer screening than traditional digital mammography

Sep 26, 2024, 17:57

Results from the ABIGAIL study presented at ESMO24

Sep 26, 2024, 17:47

Charles Gaulin: Our initiative on enhancing advance care planning for lymphoma and myeloma patients has received an ASCO Conquer Cancer Merit Award

Sep 26, 2024, 17:40

Kenji Lopez-Cuevas Is Running For The UICC Board of Directors